Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Hospira | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Hospira

Asia-Pacific sales growth outstrips other regions.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hospira 4Q10

4Q Revenues: $992.1 million (-6%)

4Q Earnings: $60.6 million (-37%)

FY Revenues: $3.9 billion (+1%)

FY Earnings: $357.2 million (-12%)

Comments: Global Specialty Injectable Pharmaceuticals sales in the quarter were $605.0 million, (+5%). Sales in the Americas were up 4%, Europe, Middle East & Africa sales were up 1%, and Asia Pacific sales were up 10%. For the year, Global Specialty Injectable Pharmaceuticals sales were $2.3 billion, up 13%. Sales in the Americas were up 15%, Europe, Middle East & Africa sales were up 4%, and Asia Pacific sales were up 12%. Results were impacted by a decline in Medication Management, primarily due to the voluntary hold on shipments of Symbiq Infusion System, and the decline in Other Pharma, as a result of the impact of non-strategic asset divestitures.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters